most effective glp-1 clinical trials outcomes The Big Trial of a drug (Wegovy) to Reduce Major Cardiovascular Events An Observational Study of Cardiovascular

Greger cuts through the promotional puffery and presents the pros and cons of these weight-loss drugs so individuals can make up their own mind in the face of the very real and devastating consequences of obesity

GLP-1 therapies reduce inflammation across organs through rapid, weight-independent immune and metabolic effects.

Among non-diabetic patients without chronic kidney disease (CKD), there was a minimal increase of 0.01 mg/dL to 0.02 mg/dL in serum creatinine in the months following initiation of semaglutide, liraglutide, or tirzepatide

Unlike injectable medications or stimulant-based appetite suppressants, GLP-1 Formula supports the bodys natural GLP-1 response using carefully selected, research-supported ingredients

Experts weigh in on the rising trend of microdosing Ozempic and Wegovy.

If youre on a GLP-1&nbsp